{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:58:11Z","timestamp":1789891091943,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T00:00:00Z","timestamp":1445644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1791-y","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T20:20:35Z","timestamp":1445718035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines"],"prefix":"10.1186","volume":"15","author":[{"given":"Luigi","family":"Pasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toma","family":"Tebaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiana","family":"Boi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Barbareschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Quattrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,24]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrn1078","volume":"4","author":"MV Chao","year":"2003","unstructured":"Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4:299\u2013309.","journal-title":"Nat Rev Neurosci"},{"key":"1791_CR2","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1038\/sj.jid.5700270","volume":"126","author":"VA Botchkarev","year":"2006","unstructured":"Botchkarev VA, Yaar M, Peters EMJ, Raychaudhuri SP, Botchkareva NV, Marconi A, et al. Neurotrophins in skin biology and pathology. J Invest Dermatol. 2006;126:1719\u201327.","journal-title":"J Invest Dermatol"},{"key":"1791_CR3","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.yexcr.2012.03.006","volume":"318","author":"G Ichim","year":"2012","unstructured":"Ichim G, Tauszig-Delamasure S, Mehlen P. Neurotrophins and cell death. Exp Cell Res. 2012;318:1221\u20138.","journal-title":"Exp Cell Res"},{"key":"1791_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203\u201316.","journal-title":"Nat Rev Cancer"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1158\/1078-0432.CCR-08-0651","volume":"15","author":"CJ Thiele","year":"2009","unstructured":"Thiele CJ, Li Z, McKee AE. On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res. 2009;15:5962\u20137.","journal-title":"Clin Cancer Res"},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.canlet.2005.07.043","volume":"232","author":"MA Pierotti","year":"2006","unstructured":"Pierotti MA, Greco A. Oncogenic rearrangements of the NTRK1\/NGF receptor. Cancer Lett. 2006;232:90\u20138.","journal-title":"Cancer Lett"},{"key":"1791_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1467-2494.2006.00321.x","volume":"28","author":"A Marconi","year":"2006","unstructured":"Marconi A, Panza MC, Bonnet-Duquennoy M, Lazou K, Kurfurst R, Truzzi F, et al. Expression and function of neurotrophins and their receptors in human melanocytes. Int J Cosmet Sci. 2006;28:255\u201361.","journal-title":"Int J Cosmet Sci"},{"key":"1791_CR8","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1172\/JCI117496","volume":"94","author":"M Yaar","year":"1994","unstructured":"Yaar M, Eller MS, DiBenedetto P, Reenstra WR, Zhai S, McQuaid T, et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. Journal of Clinical Investigation. 1994;94:1550\u201362.","journal-title":"Journal of Clinical Investigation"},{"key":"1791_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445:851\u20137.","journal-title":"Nature"},{"key":"1791_CR10","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2006.06.0442","volume":"25","author":"LA Fecher","year":"2007","unstructured":"Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol. 2007;25:1606\u201320.","journal-title":"J Clin Oncol"},{"key":"1791_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1158\/0008-5472.CAN-13-2381","volume":"74","author":"X Deschenes-Simard","year":"2014","unstructured":"Deschenes-Simard X, Kottakis F, Meloche S, Ferbeyre G. ERKs in cancer: friends or foes? Cancer Res. 2014;74:412\u20139.","journal-title":"Cancer Res"},{"key":"1791_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou C, Vredeveld L, Soengas MS, Denoyelle C, Kuilman T, van der Horst C, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005;436:720\u20134.","journal-title":"Nature"},{"key":"1791_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nrc3057","volume":"11","author":"C Nardella","year":"2011","unstructured":"Nardella C, Clohessy JG, Alimonti A, Pandolfi PP. Pro-senescence therapy for cancer treatment. Nat Rev Cancer. 2011;11:503\u201311.","journal-title":"Nat Rev Cancer"},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14748\/bmr.v24.18","volume":"24","author":"L Pasini","year":"2013","unstructured":"Pasini L. Genome-wide profiling of copy number alterations in cancer: focus on melanoma. Biomedical Reviews. 2013;24:11\u201324.","journal-title":"Biomedical Reviews"},{"key":"1791_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/gcc.22160","volume":"53","author":"S Boi","year":"2014","unstructured":"Boi S, Tebaldi T, Re A, Cantaloni C, Adami V, Barbareschi M, et al. Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients. Genes Chromosomes Cancer. 2014;53:487\u201396.","journal-title":"Genes Chromosomes Cancer"},{"key":"1791_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/gcc.20785","volume":"49","author":"A Gast","year":"2010","unstructured":"Gast A, Scherer D, Chen B, Bloethner S, Melchert S, Sucker A, et al. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study. Genes Chromosomes Cancer. 2010;49:733\u201345.","journal-title":"Genes Chromosomes Cancer"},{"key":"1791_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/gcc.21932","volume":"51","author":"K Dutton-Regester","year":"2012","unstructured":"Dutton-Regester K, Aoude LG, Nancarrow DJ, Stark MS, O\u2019Connor L, Lanagan C, et al. Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene. Genes Chromosomes Cancer. 2012;51:452\u201361.","journal-title":"Genes Chromosomes Cancer"},{"key":"1791_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, et al. A landscape of driver mutations in melanoma. Cell. 2012;150:251\u201363.","journal-title":"Cell"},{"key":"1791_CR19","doi-asserted-by":"crossref","unstructured":"Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun. 2014;5.","DOI":"10.1038\/ncomms4116"},{"key":"1791_CR20","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1038\/onc.2008.98","volume":"27","author":"WW Lockwood","year":"2008","unstructured":"Lockwood WW, Chari R, Coe BP, Girard L, Macaulay C, Lam S, et al. DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. Oncogene. 2008;27:4615\u201324.","journal-title":"Oncogene"},{"key":"1791_CR21","first-page":"1107","volume":"152","author":"S Knuutila","year":"1998","unstructured":"Knuutila S, Bj\u00f6rkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol. 1998;152:1107\u201323.","journal-title":"Am J Pathol"},{"key":"1791_CR22","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199\u2013206.","journal-title":"J Clin Oncol"},{"key":"1791_CR23","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1373\/clinchem.2008.120105","volume":"55","author":"MJ Rose-Zerilli","year":"2009","unstructured":"Rose-Zerilli MJ, Barton SJ, Henderson AJ, Shaheen SO, Holloway JW. Copy-number variation genotyping of GSTT1 and GSTM1 gene deletions by real-time PCR. Clin Chem. 2009;55:1680\u20135.","journal-title":"Clin Chem"},{"key":"1791_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ymeth.2009.12.007","volume":"50","author":"B D\u2019haene","year":"2010","unstructured":"D\u2019haene B, Vandesompele J, Hellemans J. Accurate and objective copy number profiling using real-time quantitative PCR. Methods. 2010;50:262\u201370.","journal-title":"Methods"},{"key":"1791_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/(SICI)1097-4547(20000201)59:3<356::AID-JNR9>3.0.CO;2-G","volume":"59","author":"H Yano","year":"2000","unstructured":"Yano H, Cong F, Birge RB, Goff SP, Chao MV. Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J Neurosci Res. 2000;59:356\u201364.","journal-title":"J Neurosci Res"},{"key":"1791_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006529","volume":"4","author":"E Campeau","year":"2009","unstructured":"Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One. 2009;4, e6529.","journal-title":"PLoS One"},{"key":"1791_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050859","volume":"7","author":"J Vermeire","year":"2012","unstructured":"Vermeire J, Naessens E, Vanderstraeten H, Landi A, Iannucci V, Van Nuffel A, et al. Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. PLoS One. 2012;7, e50859.","journal-title":"PLoS One"},{"key":"1791_CR28","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1038\/onc.2009.256","volume":"28","author":"AR Farina","year":"2009","unstructured":"Farina AR, Tacconelli A, Cappabianca L, Cea G, Chioda A, Romanelli A, et al. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells. Oncogene. 2009;28:4075\u201394.","journal-title":"Oncogene"},{"key":"1791_CR29","series-title":"Methods in molecular biology","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-61779-108-6_6","volume-title":"The xCELLigence system for real-time and label-free monitoring of cell viability","author":"N Ke","year":"2011","unstructured":"Ke N, Wang X, Xu X, Abassi YA. The xCELLigence system for real-time and label-free monitoring of cell viability, Methods in molecular biology, vol. 740. Totowa, NJ: Humana Press; 2011. p. 33\u201343. Methods in Molecular Biology."},{"key":"1791_CR30","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"1791_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery. 2012;2:401\u20134.","journal-title":"Cancer Discovery"},{"key":"1791_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1309\/CHFHEYAT44WWP7J3","volume":"122","author":"VA Fl\u00f8renes PhD","year":"2004","unstructured":"Fl\u00f8renes PhD VA, M\u00e6landsmo PhD G, Holm PhD R, Reich PhD R, Lazarovici PhD P, Davidson MDPDB. Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome. Am J Clin Pathol. 2004;122:412\u201320.","journal-title":"Am J Clin Pathol"},{"key":"1791_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/jid.2008.214","volume":"129","author":"R Houben","year":"2008","unstructured":"Houben R, Ortmann S, Drasche A, Troppmair J, Herold MJ, Becker JC. Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation. J Investig Dermatol. 2008;129:406\u201314.","journal-title":"J Investig Dermatol"},{"key":"1791_CR34","doi-asserted-by":"publisher","first-page":"8526","DOI":"10.1158\/0008-5472.CAN-10-1563","volume":"70","author":"PLJ Keizer de","year":"2010","unstructured":"de Keizer PLJ, Packer LM, Szypowska AA, Riedl-Polderman PE, van den Broek NJF, de Bruin A, et al. Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence. Cancer Res. 2010;70:8526\u201336.","journal-title":"Cancer Res"},{"key":"1791_CR35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng.2760","volume":"45","author":"TI Zack","year":"2013","unstructured":"Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013;45:1134\u201340.","journal-title":"Nat Genet"},{"key":"1791_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer. 2004;4:177\u201383.","journal-title":"Nat Rev Cancer"},{"key":"1791_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1535-6108(02)00017-X","volume":"1","author":"A Hellman","year":"2002","unstructured":"Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, et al. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell. 2002;1:89\u201397.","journal-title":"Cancer Cell"},{"key":"1791_CR38","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/jid.2008.21","volume":"128","author":"F Truzzi","year":"2008","unstructured":"Truzzi F, Marconi A, Lotti R, Dallaglio K, French LE, Hempstead BL, et al. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Investig Dermatol. 2008;128:2031\u201340.","journal-title":"J Investig Dermatol"},{"key":"1791_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<112::AID-IJC19>3.0.CO;2-9","volume":"82","author":"ET Walch","year":"1999","unstructured":"Walch ET, Albino AP, Marchetti D. Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells. Int J Cancer. 1999;82:112\u201320.","journal-title":"Int J Cancer"},{"key":"1791_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2014.02.021","volume":"157","author":"SS Kitambi","year":"2014","unstructured":"Kitambi SS, Toledo EM, Usoskin D, Wee S, Harisankar A, Svensson R, et al. Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule. Cell. 2014;157:313\u201328.","journal-title":"Cell"},{"key":"1791_CR41","doi-asserted-by":"publisher","first-page":"8655","DOI":"10.1128\/MCB.20.23.8655-8666.2000","volume":"20","author":"GW Reuther","year":"2000","unstructured":"Reuther GW, Lambert QT, Caligiuri MA, Der CJ. Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia. Mol Cell Biol. 2000;20:8655\u201366.","journal-title":"Mol Cell Biol"},{"key":"1791_CR42","first-page":"2881","volume":"63","author":"JM Stahl","year":"2003","unstructured":"Stahl JM, Cheung M, Sharma A, Trivedi NR, Shanmugam S, Robertson GP. Loss of PTEN promotes tumor development in malignant melanoma. Cancer Res. 2003;63:2881\u201390.","journal-title":"Cancer Res"},{"key":"1791_CR43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1101\/gad.187252.112","volume":"26","author":"LCW Vredeveld","year":"2012","unstructured":"Vredeveld LCW, Possik PA, Smit MA, Meissl K, Michaloglou C, Horlings HM, et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev. 2012;26:1055\u201369.","journal-title":"Genes Dev"},{"key":"1791_CR44","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/sj.onc.1210950","volume":"27","author":"S Courtois-Cox","year":"2008","unstructured":"Courtois-Cox S, Jones SL, Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene. 2008;27:2801\u20139.","journal-title":"Oncogene"},{"key":"1791_CR45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1016-8478(23)13957-4","volume":"26","author":"EJE Jung","year":"2008","unstructured":"Jung EJE, Kim DRD. Apoptotic cell death in TrkA-overexpressing cells: kinetic regulation of ERK phosphorylation and caspase-7 activation. Mol Cells. 2008;26:12\u20137.","journal-title":"Mol Cells"},{"key":"1791_CR46","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/sj.onc.1207267","volume":"23","author":"C-W Woo","year":"2003","unstructured":"Woo C-W, Lucarelli E, Thiele CJ. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number. Oncogene. 2003;23:1522\u201330.","journal-title":"Oncogene"},{"key":"1791_CR47","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1471-4159.2009.06507.x","volume":"112","author":"C Li","year":"2010","unstructured":"Li C, MacDonald JIS, Hryciw T, Meakin SO. Nerve growth factor activation of the TrkA receptor induces cell death, by macropinocytosis, in medulloblastoma Daoy cells. J Neurochem. 2010;112:882\u201399.","journal-title":"J Neurochem"},{"key":"1791_CR48","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/jnci\/94.6.446","volume":"94","author":"EV Sviderskaya","year":"2002","unstructured":"Sviderskaya EV, Hill SP, Evans-Whipp TJ, Chin L, Orlow SJ, Easty DJ, et al. p16(Ink4a) in melanocyte senescence and differentiation. J Natl Cancer Inst. 2002;94:446\u201354.","journal-title":"J Natl Cancer Inst"},{"key":"1791_CR49","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ccr.2006.10.003","volume":"10","author":"S Courtois-Cox","year":"2006","unstructured":"Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, et al. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell. 2006;10:459\u201372.","journal-title":"Cancer Cell"},{"key":"1791_CR50","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1038\/onc.2008.323","volume":"27","author":"C Leikam","year":"2008","unstructured":"Leikam C, Hufnagel A, Schartl M, Meierjohann S. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Oncogene. 2008;27:7070\u201382.","journal-title":"Oncogene"},{"key":"1791_CR51","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/sj.bjc.6603283","volume":"95","author":"VC Gray-Schopfer","year":"2006","unstructured":"Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA, et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer. 2006;95:496\u2013505.","journal-title":"Br J Cancer"},{"key":"1791_CR52","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/1096-911X(20001201)35:6<623::AID-MPO29>3.0.CO;2-H","volume":"35","author":"A Eggert","year":"2000","unstructured":"Eggert A, Ho R, Ikegaki N, Liu X, Brodeur GM. Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification. Med Pediatr Oncol. 2000;35:623\u20137.","journal-title":"Med Pediatr Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1791-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1791-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1791-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:01:47Z","timestamp":1718150507000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1791-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,24]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1791-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,24]]},"article-number":"777"}}